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Chemokines are important mediators of the early inflammatory response to infection and modify a wide
range of host immune responses. Functional homologs of cellular chemokines have been identified in a number
of herpesviruses, suggesting that the subversion of the host chemokine response contributes to the pathogen-
esis of these viruses. Transcriptional and reverse transcription-PCR analyses demonstrated that the murine
cytomegalovirus (MCMV) chemokine homolog, m131, was spliced at the 3* end to the adjacent downstream
open reading frame, m129, resulting in a predicted product of 31 kDa, which is significantly larger than most
known chemokines. The in vivo impact of m131/129 was investigated by comparing the replication of MCMV
mutants having m131/129 deleted (Dm131/129) with that of wild-type (wt) MCMV. Our studies demonstrate
that both wt and Dm131/129 viruses replicated to equivalent levels during the first 2 to 3 days following in vivo
infection. However, histological studies demonstrated that the early inflammatory response elicited by Dm131/
129 was reduced compared with that of wt MCMV. Furthermore, the Dm131/129 mutants failed to establish a
high-titer infection in the salivary glands. These results suggest that m131/129 possesses proinflammatory
properties in vivo and is important for the dissemination of MCMV to or infection of the salivary gland.
Notably, the Dm131/129 mutants were cleared more rapidly from the spleen and liver during acute infection
compared with wt MCMV. The accelerated clearance of the mutants was dependent on NK cells and cells of
the CD41 CD81 phenotype. These data suggest that m131/129 may also contribute to virus mechanisms of
immune system evasion during early infection, possibly through the interference of NK cells and T cells.
Chemokines comprise a large superfamily of chemoattrac-
tant cytokines that play an important role in the early inflam-
matory responses of the host against a wide range of pathogens
(39). They have the ability to modulate the movement (che-
motaxis) of leukocytes and upregulate the expression of leu-
kocyte adhesion molecules, thus promoting diapedesis and in-
filtration of cells to the inflammatory site (38). In addition,
evidence is accumulating that chemokine production has major
sequelae on a wide range of innate and adaptive host immune
responses (23).
Members of the chemokine family are structurally similar
and are classified according to the arrangement and position of
conserved amino-terminal cysteine residues (e.g., C, CC, CXC,
or CX3C, where X is any amino acid). They bind to target cells
via seven transmembrane domain, G-protein-coupling recep-
tors; the cellular distribution of the receptors determines the
leukocyte subset that predominates in different types of inflam-
mation (30). In vitro studies have demonstrated considerable
promiscuity in chemokine receptor-ligand interactions. In vivo,
it is likely that the nature of the leukocyte recruited to an
inflammatory site will depend on both the nature and kinetics
of chemokine release.
Chemokines play a critical role in the host response to a
number of viruses and in the induction of virus-induced disease
(12, 18, 22, 44). The importance of chemokines in the antiviral
response has been further implicated by the identification of
chemokines and chemokine receptor homologs encoded by a
number of large DNA viruses (reviewed in references 29 and
33). Human cytomegalovirus (HCMV), herpesvirus saimiri,
human herpesvirus 6 (HHV-6), and HHV-8 each encode a
functional chemokine receptor that, like their cellular counter-
parts, is coupled to G proteins at the cellular membrane (1, 3,
6, 20, 24). Notably, the HCMV chemokine receptor homolog,
US28, also serves as a cofactor for human immunodeficiency
virus type 1 entry into and fusion of infected cells (34). Unlike
other described viral chemokine receptors, the HHV-8 ho-
molog is constitutively active and stimulates cellular prolifera-
tion in vitro in the absence of chemokines, suggesting that it
may contribute to the transforming potential of HHV-8 in vivo
(3). Putative chemokine receptors have also been identified in
both murine and rat CMV (MCMV, RCMV) (5, 35) and have
been shown to be virulence factors in vivo (5, 14). In both
mouse herpesvirus 68 and equine herpesvirus 2, homologs to
chemokine receptors have been found, although their contri-
bution to pathogenesis remains to be determined (43, 45). In
addition to the above homologs of cell surface chemokine
receptors, a soluble CC chemokine binding protein (vCKBP)
encoded by poxviruses has been shown to block the biologic
activity of chemokines in vitro and in vivo (2, 22, 41). Further-
more, the myxoma virus gamma interferon receptor homolog
(M-T7) nonspecifically sequesters CC and CXC chemokines
via a heparin binding domain (27, 31). This additional function
of M-T7 is consistent with an increased inflammatory response
in rabbits infected with a myxoma virus mutant lacking M-T7.
Two functional CC chemokine homologs, designated vMIP-1
and vMIP-II (32), are encoded by HHV-8; the latter exhibits
broad-spectrum antagonistic activity to cellular chemokines
and inhibits the chemokine-induced chemotaxis of monocytes
(25). Interest in these viral chemokines increased when they
were shown to partially inhibit HIV infection through the bind-
ing of CC and (in the case of vMIP-II) CXC chemokine re-
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ceptors (7) that can function as coreceptors for HIV (10, 15).
Unlike their cellular counterparts, both vMIP-I and vMIP-II
are highly angiogenic in vitro, suggesting that they may con-
tribute to the pathology of Kaposi’s sarcoma, a condition that
is strongly linked to HHV-8 infection (7). The MC148 gene of
the poxvirus molluscum contagiosum virus encodes a CC che-
mokine homolog (26, 40) that also exhibits a broad-spectrum
antagonistic activity against cellular chemokines (13); the pro-
tracted replication of molluscum contagiosum virus in the ab-
sence of a host inflammatory response may thus be promoted
by the MC148 gene product. Among the human betaherpesvi-
ruses, HCMV encodes at least three chemokine homologs (8),
and sequence homologs have also been identified in HHV-6
(21). Notably, the HCMV chemokine homologs have been
detected in low-passage clinical isolates and are absent from
the attenuated, tissue culture-adapted strain, AD169, suggest-
ing that they encode virulence factors.
Since chemokines are likely to be pivotal during early anti-
viral inflammatory responses, it is presumed that virus ho-
mologs of chemokines and chemokine binding proteins may
enable the virus to evade or disarm the normal host inflam-
matory response. For poxviruses, this has been supported by in
vivo studies of poxvirus mutants with chemokine binding pro-
teins deleted, which have each been shown to elicit a more
vigorous inflammatory response than wild-type (wt) virus (22,
29). Thus, natural animal models of infection provide useful
settings to characterize the impact of viral pathogenic deter-
minants.
MCMV contains an open reading frame (ORF) designated
m131 whose product has homology with CC chemokines (28).
In this report, we demonstrate that the m131 ORF is spliced at
the 39 end to the downstream m129 ORF, producing a protein
with predicted mass of 31 kDa, which is larger than known
cellular CC chemokines (7 to 15 kDa). The biological signifi-
cance of m131/129 in the MCMV life cycle in vivo was ad-
dressed by comparing the pathogenesis of wt MCMV with that
of MCMV mutants containing a m131 ORF that either is
disrupted with a lacZ cassette (Dm131Z) or contains an intro-
duced in-frame premature stop codon (Dm131ns). While the
Dm131Z and Dm131ns virus mutants established an acute in
vivo infection comparable to wt virus, they were cleared more
rapidly from these sites of infection. Furthermore, these mu-
tants showed reduced replication in the salivary gland, which is
the major site of virus persistence and transmission. Histolog-
ical examination of the spleens and livers of infected animals
showed that wt MCMV elicited a more vigorous inflammatory
response than did Dm131Z, suggesting that m131/129 may
possess proinflammatory properties in vivo. Depletion of nat-
ural killer (NK) and CD41 CD81 T cells in vivo restored virus
titers in the spleens and livers of Dm131Z-infected mice to
levels equivalent to or approaching that of wt MCMV but did
not modify the reduced replication of Dm131Z in the salivary
gland. These results provide the first report of the biological
impact of a herpesvirus chemokine in the context of a natural
in vivo infection. Our data demonstrate that m131/129 pro-
motes the recruitment of inflammatory leukocytes to the
spleen and liver and efficient dissemination to, or replication
in, the salivary gland during wt MCMV infection, suggesting
that it is a potential chemokine agonist. Our data also demon-
strate that m131/129 interferes with the early NK- and T-cell
responses of the host, causing protracted replication in primary
sites of infection.
MATERIALS AND METHODS
Cells. Primary mouse embryo fibroblasts (MEF) were grown in minimal es-
sential medium supplemented with antibiotics and 10% newborn calf serum.
YAC-1 lymphoma cells were cultivated in suspension in RPMI supplemented
with antibiotics and 10% fetal calf serum.
Mice. Specific-pathogen-free, age-matched 6- to 8-week-old BALB/c mice
were obtained from the Animal Resource Centre, Murdoch, Australia, and
maintained under minimal disease conditions.
Virus. The virulent MCMV strain K181 Perth was used as the wt virus for
these studies, and all recombinant viruses were derived from this strain. The
Perth strain is derived from and has a restriction enzyme pattern similar to that
published for the K181 strain, but it has been passaged in vivo in this laboratory
over a number of years. All master stocks of wt MCMV used in this study were
derived from a low-passage stock. wt and mutant viruses were propagated and
subjected to titer determination on MEF as previously described (14). For in vivo
studies, virus stocks were propagated in the salivary glands of 3-week-old
BALB/c mice.
Preparation of MCMV DNA. MEF were infected with MCMV at a multiplicity
of infection of 3 to 5. When the cells exhibited an extensive cytopathic effect,
infected-cell DNA was prepared as described previously (14).
Preparation of RNA. For the preparation of wt and mutant MCMV RNA,
confluent monolayers of MEF were infected with the relevant virus at a multi-
plicity of infection of 5. Infections were performed in the presence of either
cycloheximide (50 mg/ml) or phosphonoacetic acid (250 mg/ml), and the cells
were harvested 4 h postinfection (p.i.) corresponding to immediate-early (IE)
and early (E) stages of MCMV infection. For the production of late RNA
transcripts, MEF were infected in the absence of metabolic inhibitors and har-
vested at 24 h p.i. All RNAs were prepared by the method of Chomczynski and
Sacchi (11).
Northern blot analysis. RNA samples (5 mg) were subjected to electrophoresis
under denaturing conditions, blotted onto nylon, and hybridized with [32P]dCTP-
labelled double-stranded DNA probes as previously described (14). The genomic
location (indicated in kilobase pairs) of ORFs spanning the m131 region and the
location of subgenomic fragments used as probes for Northern analysis are
shown in Fig. 1A.
Synthesis, cloning, and sequencing of m131/129 cDNA. Following first-strand
cDNA synthesis with poly d(T), the m131/129 cDNAs were amplified by PCR
with oligonucleotides PF1 (CGGAATTCTAGAATGGGAACGCTCCTCGTG
TGCTG) and PF2 (TATGAATTCTTATTCATCGGACAGTCGTTG) and Pfu
polymerase (Stratagene). The RT-PCR products were digested with EcoRI,
cloned into pcDNA3 (Invitrogen), and sequenced.
Plasmid constructs. The derivation of plasmids used in this study is shown
schematically in Fig. 1B. Genomic clones were derived from the K181 Perth
Strain of MCMV and were kindly provided by A. Scalzo (Department of Mi-
crobiology, University of Western Australia). An EcoRV fragment (nucleotides
186244 to 189836) was subcloned into the PvuII site of pGEM to generate
plasmid pGEM131/129, which contains the m131 ORF with approximately 1.6 kb
of flanking MCMV sequence. The lacZ expression cassette containing the
HCMV IE promoter and poly(A) sites was derived from pMV10 (19); the
blunt-ended HindIII fragment of pMV10 was cloned into the filled NotI site
within the m131 ORF to generate plasmid pGEMm131Z, which was used in
transfections with wt MCMV DNA to generate Dm131lacZ1 recombinants
(hereafter designated Dm131Z). Restriction analysis of pGEMm131Z confirmed
that the lacZ cassette was inserted in the opposite orientation to the m131 ORF.
For the generation of an MCMV mutant containing a premature stop codon in
the m131 ORF, (hereafter referred as Dm131ns), the oligonucleotide pair (59G
GCCTAATTAGCTGATATC39 and 59GGCCGATATCAGCTAATTA39) was
inserted into the NotI site of pGEMm131 to generate plasmid pGEMm131ns.
This insertion introduced a unique EcoRV site that was used to identify the
presence of the oligonucleotide pair. In addition, the region flanking the NotI
insertion site was sequenced to confirm the correct insertion of the oligonucle-
otide pair.
Transfection. Transfection of MEF was performed on subconfluent monolay-
ers in 35-mm dishes by the method of Chen and Okayama (9). Monolayers were
transfected with 10 mg of infected-cell MCMV DNA plus 3 to 6 mg of the plasmid
DNA of interest, using previously described methods (14). For the identification
of recombinant viruses expressing b-galactosidase, plaques were stained with
5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal). Blue plaques were
picked and cloned by at least three rounds of limiting dilution. For the genera-
tion of revertant (m131r) and Dm131ns viruses, subconfluent MEF were cotrans-
fected with Dm131Z infected-cell DNA and either pGEMm131 (m131r) or
pGEM131ns (Dm131ns). Plaques resulting from the transfection were stained
with X-Gal, and “white” (i.e., b-galactosidase-negative) plaques were picked and
cloned as above.
Southern blot analysis. Infected-cell DNA was prepared from wt MCMV- or
recombinant MCMV-infected MEF. Following digestion with either EcoRV or
SacI, the DNA was separated on a 1% agarose gel and transferred to nylon by
standard methods. The probes used were specific for either the MCMV m131
region or lacZ. DNA fragments were gel purified prior to radiolabelling and use
in hybridization experiments as specified by the manufacturer (Bresatec, Ad-
elaide, Australia).
In vitro growth of wt and recombinant viruses. Multistep growth curves for wt
and recombinant MCMVs were determined in MEF as described previously
(14).
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In vivo growth of wt and recombinant viruses. Mice were inoculated with wt,
recombinant, or revertant viruses by the intraperitoneal (i.p.) route. At desig-
nated times p.i., mice were sacrificed and their spleens, livers, and/or salivary
glands were removed. All organs were individually weighed, homogenized in-
cold minimal essential medium supplemented with 2% newborn calf serum and
centrifuged at 2,000 3 g at 4°C. The supernatant was stored at 280°C, and the
virus titer was subsequently determined on MEF.
In vivo depletion of cellular subsets. (i) During acute infection. In vivo de-
pletion of CD41 CD81 T lymphocytes was performed by i.p. inoculation of
BALB/c mice with both YTS 169.4 and YTS 191.1 cytotoxic monoclonal anti-
bodies on days 21 and 12 relative to MCMV infection. Confirmation of T-cell
depletion was determined on day 4 by fluorescence-activated cell sorter (FACS)
analysis with rat monoclonal antibodies 3.168.8 (anti-CD8) and RL-172 (anti-
CD4). Specific binding was detected with a fluorescent secondary antibody;
nonspecific binding (background) was assessed by incubating cells with normal
rat serum followed by the secondary antibody. Binding of the detecting antibod-
ies used in the FACS analysis was not inhibited by the presence of the cytotoxic
antibodies used for the in vivo depletion. In vivo depletion of NK cells was
performed by i.p. inoculation of anti-asialo GM1 on days 21 and 12 relative to
MCMV infection. NK-cell depletion was confirmed on day 14 by NK assay of
splenocytes in a standard 4-h chromium release assay with YAC-1 cells as targets.
(ii) During persistent infection. Mice were depleted of either NK cells or
CD41 CD81 T cells on days 17 and 19 relative to MCMV infection by using the
above antibodies, and the salivary glands were harvested on day 111 p.i. Deple-
tion of NK cells and CD41 CD81 T cells were confirmed by the method
described above on day 110 p.i.
Histological testing. Spleen and liver samples from wt- and Dm131Z-infected
mice and uninfected mice were harvested on day 2 p.i., incubated in Bouin’s
FIG. 1. (A) Genetic organization of the MCMV m131 region. Nucleotide positions refer to the sequenced Smith strain of MCMV. Solid ellipses indicate the
position of poly(A) signals on each strand. The specificities of subgenomic fragments used as probes in Northern hybridizations are depicted as solid bars below the
ORFs. The probe for the m131 ORF was amplified by PCR from viral DNA. (B) Construction diagrams (not drawn to scale) for plasmids used in this study. Additional
details are provided in the text.
6802 FLEMING ET AL. J. VIROL.
fixative for 16 h, and mounted in paraffin. Sections were cut and stained with
hemotoxylin and eosin. The number of inflammatory foci was counted in at least
10 liver sections. The number of nucleated inflammatory cells per focus of
infection was derived by counting the number of cells around at least 20 foci
taken at random.
GenBank accession number. The sequence of m131/129 strain K181 (Perth)
has been assigned accession no. AF124602.
RESULTS
Characterization of recombinant MCMV with a disrupted
m131 ORF. To investigate the biological significance of m131,
MCMV recombinants in which the m131 coding region had
been disrupted by insertion of the lacZ expression cassette
(Dm131Z) or the introduction of an in-frame stop codon
(Dm131ns) were constructed and characterized (Fig. 1B). A
revertant virus was also generated from one of the lacZ-posi-
tive recombinants as described in Materials and Methods.
Following three rounds of plaque purification, stocks of each
recombinant and revertant were prepared and DNA from vi-
rus-infected cells was analyzed by Southern blot hybridization.
Three Dm131Z recombinants were cloned from independent
transfections; all were analyzed by Southern blot hybridization,
and the correct insertion of lacZ was confirmed. Two of these
recombinants were further analyzed in vitro and in vivo (as
described below) and found to possess identical phenotypes.
However, for simplicity, genetic and phenotypic analysis of one
lacZ recombinant (Dm131Z), from which the revertant, m131r,
and premature translation stop mutant, Dm131ns, were de-
rived, are presented here. Figure 2 shows the result of South-
ern blot analysis of the recombinant viruses in comparison with
wt MCMV. All samples were digested with EcoRV and SacI
and hybridized to probes specific for either the m131 region or
lacZ. The bands observed for the Dm131Z and Dm131ns re-
combinants are as predicted following the insertion of either
the lacZ cassette or the oligonucleotide pair respectively, and
there is no evidence of contaminating wt virus, confirming that
the stocks are clonally pure. The bands observed for m131r
were identical to those for wt MCMV, demonstrating that the
wt profile had been rescued and that it, too, was clonally pure.
Transcriptional analysis of the m131 region in the Dm131Z
and Dm131ns recombinant viruses. To confirm that the coding
sequences flanking m131 had not been disrupted by the inser-
tion of lacZ into Dm131Z, RNA harvested at IE, E, and late
(L) times from wt- and Dm131Z-infected cells was subjected to
Northern analysis with probes specific for m128 (ie2), m129,
m131, and m132 (sgg1). Consistent with previous studies (28),
m131 was expressed as a late transcript of approximately 1 kb
in wt MCMV; insertion of the 3.8-kb lacZ cassette resulted in
a larger (.4-kb) species in the Dm131Z recombinant (Fig. 3).
Notably, m129 was also expressed in wt MCMV as a late 1-kb
transcript, which was not detected in Dm131Z, indicating that
m131 and m129 may comprise a single transcriptional unit (see
below). Transcription from the upstream adjacent gene, m132,
appeared to be unaffected by the lacZ insertion, as was that
from the 1.8-kb m128 (ie2) gene. A novel RNA species (.6 kb)
identified at IE times for Dm131Z was shown to hybridize to
lacZ and is thus likely to represent readthrough of ie2 through
to the lacZ poly(A). However, this represents a minor species
in comparison with the authentic ie2 transcript. Northern anal-
ysis of Dm131ns showed these recombinants to be identical to
wt, demonstrating that the insertion of the oligonucleotide pair
had not disrupted transcription in this region.
m131 and m129 are expressed as a single spliced transcript.
Given that both m131 and m129 are encoded by 1-kb tran-
scripts expressed with the same kinetics and that both tran-
scripts are disrupted by lacZ, we investigated the possibility
that m131 and m129 were expressed as a single, spliced tran-
scription unit. Analysis of the sequences of m131 and m129
ORFs showed a putative splice donor site at the 39 end of m131
(immediately upstream of the translational stop codon) and a
putative splice acceptor site 100 bp upstream of the initial
ATG within m129. Reverse transcription-PCR (RT-PCR)
analysis of RNA from wt MCMV was performed with primers
for first- and second-strand synthesis as described in Materials
and Methods. The size of the RT-PCR product was compared
with that of the corresponding PCR product by using infected-
cell DNA as the template. While a single PCR product of the
predicted size was observed, the RT-PCR product was approx-
imately 100 bp shorter. The RT-PCR product was cloned into
pGEM-T (Promega), and several clones were selected for se-
quencing. The results of the sequencing confirmed the exis-
tence of the spliced mRNA. The sequence of the spliced prod-
uct, the identified splice junctions, and the 82-bp intron
sequence are shown in Fig. 4. The m129 DNA sequence of the
Perth strain differs slightly from that of the published Smith
FIG. 2. Southern blot analysis of MCMV recombinants. DNA samples were
prepared from cells infected with either wt, Dm131Z, Dm131ns, or m131r virus.
Samples were digested with SacI or EcoRV, separated on a 1.0% agarose gel,
and blotted onto nylon membranes before being hybridized to radiolabelled
probes. The 3.8-kb lacZ cassette from pMV10 (19) was used as the lacZ probe;
the m131 probe was derived from genomic MCMV DNA by PCR. The predicted
positions of SacI and EcoRV sites for each of the viruses are shown schematically
below the blot. The open boxes represent the m131 ORF. The solid box repre-
sents the lacZ ORF. Predicted fragment sizes are indicated in kilobases.
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strain and has only one nonconservative amino acid change.
No changes in the m131 sequence were detected. The pre-
dicted m131/129 protein is much larger than most known cel-
lular chemokines; the C-terminal half of the protein that is
contributed by m129 does not possess a predicted transmem-
brane or anchor sequences, and thus it is unlikely that m131/
129 is a membrane glycoprotein.
m131/129 is not required for replication in fibroblasts in
vitro. Multistep growth curves were generated to determine
whether the mutation in m131 affected the growth of the re-
combinant virus in cell culture. Primary MEF were infected
with either wt MCMV or Dm131Z at a multiplicity of infection
of 0.01, and virus titers were determined at various times p.i.
(Fig. 5). No significant difference in replication between wt
K181 and Dm131Z was observed, indicating that m131/129 is
not important for growth in fibroblasts in vitro.
In vivo characterization of recombinant MCMV. To address
the biological significance of m131/129, the ability of Dm131Z
to replicate in vivo was compared with that of wt MCMV.
Figure 6 represents the results from one of three separate
challenges of BALB/c mice infected i.p. with 104 PFU of either
wt MCMV or Dm131Z. Virus titers in the spleen, liver, and
salivary glands were determined at various time points p.i. The
two viruses were equally effective in establishing infections in
the spleen and liver to high titer by day 2 p.i., suggesting that
m131/129 is not critical for the initial rounds of replication in
these organs. Notably, the clearance of Dm131Z from the
spleen and liver was accelerated compared with that of wt
MCMV. In addition, Dm131Z was significantly attenuated in
its ability to establish a high-titer persistent infection in the
salivary glands, with virus titers being ca. 103-fold lower than
those of wt virus. Results from in vivo replication studies of
m131r showed that it replicated to wt levels in the spleen and
liver during the acute phase and subsequently in the salivary
glands, confirming that the Dm131Z phenotype was attributed
FIG. 3. Northern blot analysis of RNA isolated from MCMV-infected MEF
at immediate-early (lanes 1), early (lanes 2), and late (lanes 3) times p.i. RNA
from uninfected MEF was included as a control. Total RNA (5 mg) was sepa-
rated in a denaturing agarose gel, blotted onto nylon, and hybridized with
double-stranded DNA probes. The specificity of the DNA probes is indicated in
Fig. 1A. Solid arrows denote the 1-kb m131/129 transcript in wt MCMV and in
Dm131ns.
FIG. 4. Nucleotide sequence of the splice junction determined for MCMV
m131/129. The intron sequences are displayed in lowercase type. Changes in the
nucleotide and amino acid sequence from the published Smith strain are under-
lined; the cysteine residues conserved with cellular CC chemokines and the
predicted initiating methionine residues for m131 and m129 are doubly under-
lined. The NotI site used for the insertion of the lacZ cassette and oligonucleo-
tide pair is underscored by a dashed line. The predicted signal sequence and
N-linked glycosylation sites (N-X-T/S, where X is any amino acid) are shown in
italics.
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to the disruption of the m131 ORF rather than to adventitious
mutations elsewhere in the MCMV genome (data not shown).
To further establish a role for m131/129 in the early and per-
sistent replication of MCMV in vivo, the growth of Dm131ns
was compared with that of m131r and Dm131Z in BALB/c
mice. Like the Dm131Z mutant, the Dm131ns mutant was
cleared more rapidly than m131r in the spleen and liver during
acute infection and failed to establish a high-titer infection in
the salivary glands (Fig. 7).
Accelerated clearance of Dm131Z during acute infection is
mediated by T cells and NK cells. Given that Dm131Z and
Dm131ns were cleared more rapidly from the spleen and liver
during acute infection than was wt MCMV, we investigated
whether this was due to an altered ability of the host to combat
the virus during this period rather than to a defect in the ability
of mutant viruses to spread from cell to cell within these
organs. The timing of the clearance of the virus mutants is
consistent with a heightened T-cell response. Accordingly, the
role of CD41 CD81 T-lymphocyte populations in this accel-
erated clearance was assessed by using the Dm131Z mutant.
Although protection mediated by NK cells is usually observed
by day 2 p.i., when wt and mutant viruses exhibit equivalent
titers, the role of NK cells in the clearance of Dm131Z was also
assessed. Mice depleted in vivo of either NK cells or CD41
CD81 lymphocytes (as described in Materials and Methods)
were infected with wt MCMV or the Dm131Z mutant. Virus
titers were determined on day 5 p.i., the time when the most
significant differences in virus titers in the spleen and liver
between wt-infected and Dm131Z-infected mice were repro-
ducibly observed in immunocompetent mice. The efficacy and
specificity of the NK-cell and CD41 CD81-T-cell depletion
regimens were assessed on day 4 p.i. (data not shown). NK-cell
depletion was assessed by measuring the NK-cell activity of
splenocytes with YAC-1 targets in a standard 4-h lysis assay. In
vivo depletion of asialo GM1-positive cells reduced the levels
of NK activity in wt- and Dm131Z-infected mice to the level
observed in control (uninfected) animals. In addition, the de-
pletion of CD41 CD81 T cells did not affect the NK-cell
activity in these groups. The efficacy of CD41 CD81-T-cell
depletion was assessed by analyzing the profile of CD41 and
CD81 lymph node cells by FACS analysis on day 4 p.i. The
percentage of cells positive for CD4 and CD8 markers was
reduced to background levels (as described in Materials and
Methods) in depleted animals but was unaffected by anti-asialo
GM1 treatments.
The effects of NK-cell and CD41 CD81-T-cell depletion on
replication of wt MCMV and Dm131Z in the spleen and liver
are shown in Fig. 8A and B. As expected, Dm131Z-infected
immunocompetent mice sustained a significantly lower titer of
FIG. 5. Multistep growth curves of wt MCMV and Dm131Z in MEF. Con-
fluent monolayers were infected with 0.01 PFU of either wt ( n ) or Dm131Z ({)
virus per cell. Following virus adsorption (1 h at 37°C), monolayers were washed,
fresh medium was added, and the mixture was incubated for various time points
before the cells and supernatant were harvested. Samples were stored at 280°C
before being used for titer determination on MEF. Each point represents the
log10 of the mean PFU per milliliter, with one standard deviation, of triplicate
samples. The in vitro growth rates of m131r and Dm131ns were also shown to be
similar to those of wt virus and are not presented in the figure.
FIG. 6. Growth of wt (black bars) and Dm131Z (grey bars) virus in the
spleens (A), livers (B), and salivary glands (C). Groups of four BALB/c mice
were infected i.p. with 104 PFU of the relevant virus, and spleens, livers, and
salivary glands were harvested on the days indicated. Organs were homogenized
and stored at 280°C before being used for titer determination on MEF. Virus
titers are expressed as mean log10 per organ, with standard error. The y axis is
cropped to indicate the lower limit of virus detection. N.D, not determined.
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virus in the spleen and liver than did wt-infected mice. In the
spleen, neither NK- nor CD41 CD81-T-cell depletion caused
increased titers in wt-infected mice, consistent with previous
studies (17). However, in Dm131Z-infected animals, NK- and
CD41 CD81-T-cell depletion resulted in elevated titers of
virus in the spleen, equivalent to the titers in wt-infected ani-
mals. NK and CD41 CD81 depletions caused increases in the
virus titer of Dm131Z in the liver that were in excess of those
observed for wt-infected mice. Taken together, these results
demonstrate that restriction of virus replication by NK cells or
CD41 CD81 T cells contributes to the observed attenuation of
Dm131Z during acute infection of immunocompetent animals.
Neither NK cells nor CD41 CD81 T cells contribute to the
restricted replication of Dm131Z in the salivary gland. To
determine whether NK cells or CD41 CD81 T cells restrict the
replication of Dm131Z in the salivary gland, mice were de-
pleted of either of these cell subsets 7 days p.i. and the salivary
glands were harvested on day 11 p.i. This time point was
chosen for immune system depletion since it corresponded to
the time of virus clearance from the spleen and liver and the
initiation of virus replication in the salivary gland. Immune
system depletion prior to MCMV infection was not possible in
this study, since this leads to overwhelming titers in the spleen
and liver prior to the full establishment of virus replication in
the salivary glands and is accompanied by high morbidity and
mortality rates.
The Dm131Z mutant exhibited restricted replication in both
immune system-depleted and immunocompetent animals,
demonstrating that the attenuated phenotype of Dm131Z in
the salivary glands is not due to enhanced NK-cell- or CD41
CD81-T-cell-mediated control of virus replication (Fig. 8C).
Histological comparison of wt and Dm131Z infections in
vivo. Previous studies have shown that MCMV induces an
early focal inflammation in the liver and spleen following in-
traperitoneal infection. To characterize the contribution of
m131/129 to the inflammatory responses, samples were iso-
lated from infected mice on day 2 p.i., when mutant and wt
viruses replicate to equivalent levels. Tissue sections were pre-
pared and stained with hematoxylin and eosin for morpholog-
ical analyses of the inflammatory response. In the liver, wt-
infected tissues exhibited a larger number of inflammatory foci
(29 6 3) than did Dm131Z-infected tissues (14 6 2). Further-
more, when the numbers of leukocytes around each focus of
infection were compared (Fig. 9), it was noted that foci in
FIG. 7. Growth of m131r (shaded bars), Dm131ns (stippled bars), and
Dm131Z (solid bars) in vivo. Groups of four BALB/c mice were infected i.p. with
104 PFU of the relevant virus. Organs were harvested and homogenized on the
days indicated and stored at 280°C before being used for titer determination on
MEF. Virus titers are expressed as the mean log10 per organ, with standard error.
The y axis is cropped to indicate the lower limit of virus detection. S.G., salivary
glands.
FIG. 8. Effect of NK-cell and CD41 CD81-T-cell depletion on the replica-
tion of wt and Dm131Z in the spleen (A), liver (B) and salivary gland (C). The
methods used for in vivo depletion of NK cells (stippled bars) and CD41 CD81
T cells (open bars) is described in the text. Undepleted mice (solid bars) were
used as controls. All mice received 104.3 PFU of either wt or Dm131Z. Virus
titers in the spleen and liver were determined on day 5 p.i.; virus titers in the
salivary gland were determined in a separate study on day 11 p.i. Each group
represents the log10 of the mean PFU per organ, with one standard deviation,
from five mice. The y axis is cropped to indicate the lower limit of virus detection.
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FIG. 9. Dm131Z elicits a reduced inflammatory infiltrate in the livers of infected mice. Samples were prepared from livers of wt- and Dm131Z-infected BALB/c mice
harvested 2 days p.i. (a and b) The number of foci of infection observed for the wt (a) and recombinant (b) viruses. Magnification, 322.75. Foci of infection are marked
by arrows. (c and d) The number of inflammatory cells surrounding each focus of infection for the wt (c) and Dm131Z (d) viruses. Magnification, 336.4.
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wt-infected tissues contained more inflammatory cells (26 6 3)
than did foci in Dm131Z-infected tissues (14 6 3). These
findings suggest that m131/129 promotes an early inflamma-
tory response and recruits cells to the sites of infection.
DISCUSSION
Chemokines and their receptors are common targets for
subversion or exploitation by persistent viruses, demonstrating
their importance in the host response to virus infection. Since
homologs of chemokines and chemokine receptors are wide-
spread among the gamma- and betaherpesviruses, they may
provide a function that is intrinsic to the in vivo life cycle of
these herpesvirus subfamilies. Since a distinguishing feature of
the gamma- and betaherpesviruses is their ability to replicate
in leukocytes, it is perhaps not surprising that these subgroups
encode proteins that have the potential to modify leukocyte
homeostasis. Possible functions of viral chemokines and/or
chemokine receptors include (i) the attraction of uninfected
leukocytes to the site of infection (recruitment of susceptible
targets), (ii) the trafficking of infected leukocytes to sites of
protracted virus shedding (virus dissemination and transmis-
sion), (iii) the binding of virus to specific cell types (virus
tropism), and (iv) the blocking of host chemokine-dependent
mechanisms of virus clearance (immune evasion).
We have examined the biological significance of the putative
MCMV CC chemokine homolog by comparing the dissemina-
tion of wt MCMV with MCMV mutants with an intact m131/
129 ORF deleted. The results of this study indicate that m131/
129 may possess both proinflammatory and immune system-
evasive properties.
First, histological examination of wt- or Dm131Z-infected
organs showed that m131/129 contributed to the early recruit-
ment of inflammatory cells to the spleen and liver. Since
MCMV replication is highly cell associated (42), it is possible
that m131/129 acts as a chemokine agonist, recruiting leuko-
cytes that provide a source of susceptible targets. Recent evi-
dence has shown that m131 elicits a calcium flux with a proin-
flammatory role (36). Studies are in progress to identify the
cells comprising the inflammatory infiltrate and to determine
their susceptibility to MCMV infection.
In comparison with wt MCMV, both Dm131Z and Dm131ns
mutants exhibited reduced titers in the salivary glands of in-
fected animals. This restricted dissemination was shown to be
independent of host NK cells or CD41 CD81 T lymphocytes.
Thus, it is possible that m131/129 plays a role in either virus
dissemination to or infection of the salivary glands. Notably,
the putative MCMV chemokine receptor, encoded by M33,
and its counterpart in RCMV (R33) play a critical role in
salivary gland tropism. Given that the salivary gland is a major
site of CMV transmission, it would be anticipated that the
retention of ORFs that encode determinants of MCMV
growth in salivary glands would provide a selective advantage
in the natural setting. Indeed, sequence analysis of tissue cul-
ture-adapted HCMV strains AD169 and Towne has shown
that these strains lack a considerable portion of the genome,
including the chemokine homologs, that is present in the re-
cent clinical Toledo strain. Sequence analysis of multiple field
isolates of MCMV has shown that the chemokine receptor
homolog, M33, is highly conserved (16); similarly, it would be
of interest to determine whether m131/129 is also conserved.
Second, our studies demonstrated that although virus titers
in the spleens and livers of Dm131Z, Dm131ns, and wt-infected
animals were equivalent on day 2 p.i., the mutant viruses were
cleared more rapidly. This rapid clearance was dependent on
the NK-cell and (to a lesser extent) the CD41 CD81 T-cell
compartment. Recent studies have shown that the cellular CC
chemokine, MIP-1a, recruits NK cells to the liver as early as
days 2 and 3 following MCMV infection (37). Given the ho-
mology of m131/129 to cellular CC chemokines, it is tempting
to suggest that m131/129 interferes with the chemokine-depen-
dent pathways of NK-cell- and T-cell-mediated virus clearance.
Given the proinflammatory properties of m131/129, it may
recruit cells to sites of infection that downregulate NK-cell and
T-cell function. Alternatively, m131/129 may directly block
NK- and T-cell activation or modulate cell surface adhesion
molecules that are important for effector-target conjugate for-
mation.
While first described as inducible mediators of inflamma-
tion, chemokines are now known to play a pivotal role in the
shaping of the innate and adaptive immune system responses
to infection. The results of our in vivo studies suggest that
m131/129 may interfere with the early events in the host cel-
lular response to MCMV infection, thus contributing to pro-
tracted virus replication and improved virus dissemination
within the host. Taken together, our data suggest contrasting
agonist and antagonist roles for m131/129, namely, increased
recruitment of leukocytes to foci of infection together with
inhibition of NK- and T-cell-mediated clearance. Such proin-
flammatory and inhibitory properties have also been described
for the HHV-8 CC chemokine homolog, vMIP-II, which is a
potent chemoattractant for eosinophils yet blocks the chemo-
taxis of monocytes (25).
Transcriptional analysis of the m131 region has identified a
number of spliced ORFs. Spliced late herpesvirus transcripts
are uncommon, and in this respect the m131/129 spliced tran-
script is unusual. Cellular CC chemokines are also spliced, with
a conserved structure comprising three exons, but none of the
intron-exon boundaries are positioned similarly to m131/129.
The product of m131/129 has a predicted mass of 31K, which
is significantly larger than that of most other known cellular
chemokines. The only cellular chemokine that has a similar
mass to m131/129 is the membrane-bound CX3C chemokine,
fractalkine (4). Unlike fractalkine, however, m131/129 is not
predicted to be membrane bound. The significance of the con-
tribution of m129 to the function of m131/129 is uncertain,
since the homology of m131/129 to CC chemokines is located
entirely within the m131 ORF and m129 does not have homol-
ogy to other sequences in the published databases. Future
structure-function studies will be important to evaluate the
contribution of the m129 moiety to the function of m131/129.
It is now apparent that MCMV possesses multiple genes that
contribute to virulence, either by interfering with host immune
responses or by modifying virus dissemination and/or tropism.
To our knowledge, this is the first demonstration that a her-
pesvirus chemokine homolog can modulate the early cell-me-
diated immune response in vivo. Since chemokine homologs
are present in a number of herpesviruses that lack suitable in
vivo models, the analysis of these and other conserved viru-
lence genes in MCMV provides a valuable biological system to
determine the role of these genes in infection of the natural
host.
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